Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Exosomes in lung cancer liquid biopsies: Two sides of the same coin?
Rolfo C, Giallombardo M, Reclusa P, Sirera R, Peeters M. Rolfo C, et al. Among authors: sirera r. Lung Cancer. 2017 Feb;104:134-135. doi: 10.1016/j.lungcan.2016.11.014. Epub 2016 Nov 18. Lung Cancer. 2017. PMID: 27894607 No abstract available.
Exosomes genetic cargo in lung cancer: a truly Pandora's box.
Reclusa P, Sirera R, Araujo A, Giallombardo M, Valentino A, Sorber L, Bazo IG, Pauwels P, Rolfo C. Reclusa P, et al. Among authors: sirera r. Transl Lung Cancer Res. 2016 Oct;5(5):483-491. doi: 10.21037/tlcr.2016.10.06. Transl Lung Cancer Res. 2016. PMID: 27826529 Free PMC article. Review.
Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.
Valentino A, Reclusa P, Sirera R, Giallombardo M, Camps C, Pauwels P, Crispi S, Rolfo C. Valentino A, et al. Among authors: sirera r. Clin Transl Oncol. 2017 Jun;19(6):651-657. doi: 10.1007/s12094-016-1599-5. Epub 2017 Jan 4. Clin Transl Oncol. 2017. PMID: 28054319 Review.
Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer.
Malapelle U, Sirera R, Jantus-Lewintre E, Reclusa P, Calabuig-Fariñas S, Blasco A, Pisapia P, Rolfo C, Camps C. Malapelle U, et al. Among authors: sirera r. Expert Rev Mol Diagn. 2017 Mar;17(3):209-215. doi: 10.1080/14737159.2017.1288568. Epub 2017 Feb 9. Expert Rev Mol Diagn. 2017. PMID: 28129709 Review.
FGFR a promising druggable target in cancer: Molecular biology and new drugs.
Porta R, Borea R, Coelho A, Khan S, Araújo A, Reclusa P, Franchina T, Van Der Steen N, Van Dam P, Ferri J, Sirera R, Naing A, Hong D, Rolfo C. Porta R, et al. Among authors: sirera r. Crit Rev Oncol Hematol. 2017 May;113:256-267. doi: 10.1016/j.critrevonc.2017.02.018. Epub 2017 Mar 23. Crit Rev Oncol Hematol. 2017. PMID: 28427515 Review.
Oncogenic role of arsenic exposure in lung cancer: A forgotten risk factor.
Soza-Ried C, Bustamante E, Caglevic C, Rolfo C, Sirera R, Marsiglia H. Soza-Ried C, et al. Among authors: sirera r. Crit Rev Oncol Hematol. 2019 Jul;139:128-133. doi: 10.1016/j.critrevonc.2019.01.012. Epub 2019 Jan 25. Crit Rev Oncol Hematol. 2019. PMID: 30878179 Review.
Lung Cancer and Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Identifying Important Knowledge Gaps for Investigation.
Rolfo C, Meshulami N, Russo A, Krammer F, García-Sastre A, Mack PC, Gomez JE, Bhardwaj N, Benyounes A, Sirera R, Moore A, Rohs N, Henschke CI, Yankelevitz D, King J, Shyr Y, Bunn PA Jr, Minna JD, Hirsch FR. Rolfo C, et al. Among authors: sirera r. J Thorac Oncol. 2022 Feb;17(2):214-227. doi: 10.1016/j.jtho.2021.11.001. Epub 2021 Nov 10. J Thorac Oncol. 2022. PMID: 34774792 Free PMC article. Review.
64 results